DONNA LUKE: Open Payments
NPI 1760062038 · BOCA RATON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,434 in 127 payments from 28 companies in 2025. Trend: 2023 $2,306 · 2024 $3,186 · 2025 $3,434
Food & beverage: $3,434
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $596 |
| Eisai Inc. | 13 | $427 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $287 |
| Merz Pharmaceuticals, LLC | 7 | $251 |
| Teva Pharmaceuticals USA, Inc. | 3 | $243 |
| Neurelis, Inc. | 10 | $177 |
| UCB, Inc. | 5 | $156 |
| Axsome Therapeutics, Inc. | 2 | $154 |
| Lilly USA, LLC | 8 | $153 |
| Neurocrine BioSciences, Inc. | 6 | $138 |
Products named: Leqembi, HYQVIA, QULIPTA, AUSTEDO XR, INBRIJA, UBRELVY, VALTOCO, Symbravo.
Industry payments across FL — which companies pay providers there.
